Surface ECG and Sensor Data Acquisition of HF Recovery
Study Type/Phase: Feasibility
Status: Not Recruiting
Heart Failure (HF) affects 5.8 million patients in the United States and 23 million globally. There is a clinical need for cost-effective, less burdensome, and more effective treatment options. The goal is to enable healthcare providers to manage and treat heart failure in a way that ultimately reduces or prevents hospital readmissions.
To gather the data towards this goal, this study uses a lightweight, noninvasive device to collect cardiac data. The device uses custom-made, patch sensors that temporarily adhere to the torso of the patient and connect to a recording unit. The sensors, which are like patch electrodes used to collect electrocardiograms, collect physiological data that may correlate with changing heart failure status. The data collected will be used to investigate whether heart failure episodes can be predicted before the onset of symptoms so that patients and providers can take action to prevent hospital readmission. The intent of this study is for data collection and research purposes only.
Up to 50 patients will be enrolled at El Camino Hospital Mountain View location.
Speak with your doctor to determine whether you meet the following criteria for participation in this study.
|Inclusion Criteria||Exclusion Criteria|